Nopal and Pirfenidone Ameliorate Epididymal Fat Weight and Anthropometric Parameters in a Mouse Obesity Model with Diethylnitrosamine
Introduction and Objectives: Obesity is associated with liver diseases. Mexico has a high prevalence of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Nopal and Pirfenidone (PFD) increase insulin signaling and decrease hepatic steatosis in obese mice. We investigated P...
Saved in:
| Main Authors: | Jorge Gutiérrez-Cuevas, Daniel López-Cifuentes, Ana S. Sandoval-Rodríguez, Juan Armendariz-Borunda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268125000833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pirfenidone Prevents Myocarditis by Restoring Metabolic Hormone Levels in a Mouse MASH Model and its Effect on H9c2 Myoblast Viability under Glucolipotoxicity
by: Daniel López-Cifuentes, et al.
Published: (2025-04-01) -
Pirfenidone limits the progression of malignancy and slows the development of fibrosis in experimental hepatocarcinoma.
by: Scarlet Arceo-Orozco, et al.
Published: (2025-04-01) -
Characterization and ameliorative effects of Chenopodium murale hydroethanolic extract against diethylnitrosamine-induced hepato-renal damage and malfunction
by: Howida S. Abou- Seif, et al.
Published: (2023-12-01) -
Iron elevation and adipose tissue remodeling in the epididymal depot of a mouse model of polygenic obesity.
by: Xiaoya Ma, et al.
Published: (2017-01-01) -
Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients
by: Simón A. Ojeda-Duran, et al.
Published: (2020-05-01)